CAAS Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,812
| Closed | -$789K | – | 214 |
|
|
2024
Q3 | $789K | Buy |
11,812
+8,504
| +257% | +$568K | 0.09% | 30 |
|
|
2024
Q2 | $393K | Buy |
3,308
+308
| +10% | +$36.6K | 0.13% | 27 |
|
|
2024
Q1 | $320K | Sell |
3,000
-1,500
| -33% | -$160K | 0.02% | 55 |
|
|
2023
Q4 | $448K | Buy |
+4,500
| New | +$448K | 0.05% | 33 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 386 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 456 |
|
|
2022
Q4 | – | Sell |
-11,532
| Closed | -$1.36M | – | 557 |
|
|
2022
Q3 | $1.36M | Buy |
11,532
+6,764
| +142% | +$800K | 0.07% | 114 |
|
|
2022
Q2 | $681K | Buy |
+4,768
| New | +$681K | 0.03% | 179 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 531 |
|
|
2021
Q4 | – | Sell |
-891
| Closed | -$343K | – | 608 |
|
|
2021
Q3 | $343K | Sell |
891
-1,053
| -54% | -$405K | 0.01% | 379 |
|
|
2021
Q2 | $457K | Sell |
1,944
-26,431
| -93% | -$6.21M | 0.01% | 453 |
|
|
2021
Q1 | $3.72M | Buy |
+28,375
| New | +$3.72M | 0.04% | 194 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 550 |
|